GSK acquires 35Pharma for $950M. The primary focus is HS235, a selective PH drug reducing bleeding risk with metabolic ...

One of the reasons why rare disease, medications take so long to get to the clinic is because we have very specific ...

Univar Solutions LLC announced on February 24, 2026 that its Ingredients + Specialties from Univar Solutions division has been appointed as the distributor for Ingredion Pharma Solutions, creating an ...

In response to Marty Makary warning the US may lose the early‑stage drug development lead to China, Brian Scanlan says speed, ...

In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...

A structured pathway supports individualized RNA-based and genome-editing therapeutics when ultra-rare prevalence precludes ...

Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before ...

Using patent intelligence data from the FounderNest platform, Gonzalez highlights where small-molecule synthesis, formulation ...

A: No new regulations were published in 2025 specific to data integrity. The evolving global regulatory systems do, however, ...

In response to Marty Makary warning the US may lose the early‑stage drug development lead to China, Brian Scanlan says speed, ...

The rapid pace of digitalization has created a skills gap, necessitating that staff with traditional chemistry or biology ...

Tevard Biosciences, joining the leadership team in 2025 to spearhead the company’s pioneering tRNA-based gene therapies for ...